In the original version of this article (1), Ovcar3 cell line data in Fig. 2D was a duplicate of the Ovcar10 cell line data. This duplication was inadvertent and does not affect the main conclusions of the study. The graph for Ovcar3 has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

1.
Dahl
ES
,
Buj
R
,
Leon
KE
,
Newell
JM
,
Imamura
Y
,
Bitler
BG
, et al
Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer
.
Mol Cancer Res
2019
;
17
:
1710
20
.